Articles and resources

Prenatal
24 Nov 2021

Implications of Fetal Fraction measurement variability in NIPS – Webinar Transcript

The lecture entitled “Implications of fetal fraction measurement variability in NIPS” was presented by Dr Fredrik Persson at the 2021 International Society for Prenatal Diagnosis (ISPD) conference.
Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study)
Prenatal
08 Oct 2021

Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study)

Pooh, R.K.; Masuda, C.; Matsushika, R.; Machida, M.; Nakamura, T.; Takeda, M.; Ohashi, H.; Kumagai, M.; Uenishi, K.; Roos, F.; Persson, F.; Shimokawa, O. Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study). Diagnostics 2021, 11, 1837. https://doi.org/10.3390/diagnostics11101837
Evaluation of repeat testing of a non-sequencing based NIPT test on a Finnish general-risk population
Prenatal
07 Sep 2021

Evaluation of repeat testing of a non-sequencing based NIPT test on a Finnish general-risk population

Karlsson F, Ahola T, Dahlberg J, Prensky L, Moilanen H, Spalding H. Evaluation of repeat testing of a non- sequencing based NIPT test on a Finnish general- risk population. Acta Obstet Gynecol Scand. 2021;100:1497–1500. https://doi.org/10.1111/aogs.14125
Understanding Fetal Fraction in cfDNA screening
Prenatal
30 Aug 2021

Understanding Fetal Fraction in cfDNA screening

Fetal fraction has been used by some laboratories to determine if they can have confidence in their results. However, there are significant factors to consider when determining its merit, including assay precision, the accuracy of a reported fetal fraction metric and the implications of using a fetal fraction cutoff. In the enclosed publication, we present the science, the data and the impact of using the fetal fraction metric within a clinical context.
Evaluation of Vanadis system as an alternative method for cell-free fetal DNA assay in maternal plasma
Prenatal
22 Jun 2021

Evaluation of Vanadis system as an alternative method for cell-free fetal DNA assay in maternal plasma

Imma Mercadé, Robin Wijngaard, Javier Laguna, Maria Rodriguez, Elena Casals. Servicio de Bioquímica y Genética Molecular, CDB, Hospital Clínic de Barcelona. Poster presented at the ECPM conference 2021.
Variability of “Reported Fetal Fraction” in Noninvasive Prenatal Screening (NIPS)
Prenatal
18 Mar 2021

Variability of “Reported Fetal Fraction” in Noninvasive Prenatal Screening (NIPS)

Persson et al., Clinical Chemistry, 2021
Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies
Prenatal
23 Nov 2020

Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies

Huang et al., BMC Pregnancy and Childbirth, 2020. Provided by the Springer Nature SharedIt content-sharing initiative. No modifications were made on this material. https://creativecommons.org/licenses/by/4.0/
Minimizing Patients’ Risk of Adverse Outcomes in NIPT
Prenatal
26 Sep 2020

Minimizing Patients’ Risk of Adverse Outcomes in NIPT

Lawrence Prensky, MS, LCGC, CCGC, discusses the challenges within NIPT on one of the biggest stages in prenatal health, the CoGEN 2020 World Conference.
Making NIPT accessible to all women
Prenatal
26 Jun 2020

Making NIPT accessible to all women

This webinar aims to address some of the obstacles that have prevented the widescale adoption of NIPT. Issues such as: cost, focus, precision and ease of use will all be examined by our speakers and then reevaluated using PerkinElmer's new Vanadis® NIPT platform. Speakers include Prof. Howard Cuckle (Tel Aviv University, Israel) and Dr Alka Chaubey (PerkinElmer Global Genomic, USA)
Universal access to NIPT: Cost-effective and precise cell-free DNA testing
Prenatal
08 Jun 2020

Universal access to NIPT: Cost-effective and precise cell-free DNA testing

This PerkinElmer satellite symposium organized at the European Society of Human Genetics (ESHG) Virtual Conference 2020 presents two laboratories’ experience with Vanadis® NIPT, an automated, non-sequencing cell-free DNA testing platform. Speakers include Dr. Alka Chaubey (PerkinElmer Global Genomic, USA) and Prof. Barbara Pasini (University of Turin, Italy).

Products may not be licensed in accordance with the laws in all countries, such as the United States, Canada. Please check with your local representative for availability.

PerkinElmer does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.